Skip to main navigation Skip to search Skip to main content

Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling

  • Steven T. Haller
  • , Yanling Yan
  • , Christopher A. Drummond
  • , Joe Xie
  • , Jiang Tian
  • , David J. Kennedy
  • , Victoria Y. Shilova
  • , Zijian Xie
  • , Jiang Liu
  • , Christopher J. Cooper
  • , Deepak Malhotra
  • , Joseph I Shapiro
  • , Olga V. Fedorova
  • , Alexei Y. Bagrov

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalPharmaceutical Science and Research
StatePublished - Jan 1 2016

Keywords

  • cardiac fibrosis
  • cardiomyopathy
  • cardiovascular diseases
  • fibrosis
  • heart failure

Disciplines

  • Medical Sciences
  • Medical Specialties
  • Medicine and Health Sciences

Cite this